Graft-versus-host disease screening

Graft-versus-host disease
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Graft-versus-host disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Graft-versus-host disease screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Graft-versus-host disease screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Graft-versus-host disease screening
CDC on Graft-versus-host disease screening
Graft-versus-host disease screening in the news
Blogs on Graft-versus-host disease screening
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Graft-versus-host disease screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There is no role for screening for GvHD. However, there is a significant role for primary prevention.